Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Description
Osilodrostat (LCI699)is a potent inhibitor of human 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) with IC50 values of 2.5 and 0.7 nM, respectively, and has been approved by the FDA for the treatment of Cushing's disease.